ArticleJournal of clinical medicine2023

Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.

Wei-Ru Chiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.